Logo image of OPRX

OPTIMIZERX CORP (OPRX) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:OPRX - US68401U2042 - Common Stock

13.16 USD
-0.2 (-1.5%)
Last: 1/9/2026, 8:15:10 PM
13 USD
-0.16 (-1.22%)
After Hours: 1/9/2026, 8:15:10 PM

OPRX Key Statistics, Chart & Performance

Key Statistics
Market Cap245.30M
Revenue(TTM)109.51M
Net Income(TTM)32.00K
Shares18.64M
Float15.58M
52 Week High22.25
52 Week Low3.99
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.82
PE16.05
Fwd PE14.69
Earnings (Next)03-10 2026-03-10/amc
IPO2005-05-18
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology


OPRX short term performance overview.The bars show the price performance of OPRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

OPRX long term performance overview.The bars show the price performance of OPRX in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 100

The current stock price of OPRX is 13.16 USD. In the past month the price decreased by -5.12%. In the past year, price increased by 145.52%.

OPTIMIZERX CORP / OPRX Daily stock chart

OPRX Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 31.02 39.47B
DOCS DOXIMITY INC-CLASS A 26.7 8.24B
WAY WAYSTAR HOLDING CORP 25.75 6.60B
HTFL HEARTFLOW INC N/A 2.82B
CERT CERTARA INC 18.66 1.49B
SDGR SCHRODINGER INC N/A 1.35B
TDOC TELADOC HEALTH INC N/A 1.32B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP 646.5 1.10B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.07B
PHR PHREESIA INC N/A 1.03B
GDRX GOODRX HOLDINGS INC-CLASS A 8 950.40M
HSTM HEALTHSTREAM INC 32.5 655.71M

About OPRX

Company Profile

OPRX logo image OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

Company Info

OPTIMIZERX CORP

260 Charles Street, Suite 302

Waltham MASSACHUSETTS 48307 US

CEO: William Febbo

Employees: 106

OPRX Company Website

OPRX Investor Relations

Phone: 12486516558

OPTIMIZERX CORP / OPRX FAQ

What does OPTIMIZERX CORP do?

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.


Can you provide the latest stock price for OPTIMIZERX CORP?

The current stock price of OPRX is 13.16 USD. The price decreased by -1.5% in the last trading session.


Does OPTIMIZERX CORP pay dividends?

OPRX does not pay a dividend.


How is the ChartMill rating for OPTIMIZERX CORP?

OPRX has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


How is the valuation of OPTIMIZERX CORP (OPRX) based on its PE ratio?

The PE ratio for OPTIMIZERX CORP (OPRX) is 16.05. This is based on the reported non-GAAP earnings per share of 0.82 and the current share price of 13.16 USD.


What is the market capitalization of OPRX stock?

OPTIMIZERX CORP (OPRX) has a market capitalization of 245.30M USD. This makes OPRX a Micro Cap stock.


What is the next earnings date for OPRX stock?

OPTIMIZERX CORP (OPRX) will report earnings on 2026-03-10, after the market close.


OPRX Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to OPRX. When comparing the yearly performance of all stocks, OPRX is one of the better performing stocks in the market, outperforming 93.75% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OPRX Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to OPRX. OPRX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OPRX Financial Highlights

Over the last trailing twelve months OPRX reported a non-GAAP Earnings per Share(EPS) of 0.82. The EPS increased by 182.76% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.03%
ROA 0.02%
ROE 0.03%
Debt/Equity 0.2
Chartmill High Growth Momentum
EPS Q2Q%66.67%
Sales Q2Q%22.33%
EPS 1Y (TTM)182.76%
Revenue 1Y (TTM)24.18%

OPRX Forecast & Estimates

13 analysts have analysed OPRX and the average price target is 24.82 USD. This implies a price increase of 88.6% is expected in the next year compared to the current price of 13.16.

For the next year, analysts expect an EPS growth of 131.3% and a revenue growth 19.98% for OPRX


Analysts
Analysts83.08
Price Target24.82 (88.6%)
EPS Next Y131.3%
Revenue Next Year19.98%

OPRX Ownership

Ownership
Inst Owners75.22%
Ins Owners12.92%
Short Float %10.87%
Short Ratio6.18